Patent · US Active

Substituted 8-[6-amino-3pyridyl]xanthines

US7875608B2 · kind B2 · utility

6Cited by
7References
24Claims
0Family size

Inventors

Key dates

Filing dateDec 17, 2008
Grant dateJan 25, 2011
Priority date
Expiry dateDec 24, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides substituted 8-[6-amino-3-pyridyl]xanthines like the compound shown in the following formula:and pharmaceutical compositions that are selective antagonists of A2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.